Chemoresistance, Cancer Stem Cells, and miRNA Influences: The Case for Neuroblastoma

Neuroblastoma is a type of cancer that develops most often in infants and children under the age of five years. Neuroblastoma originates within the peripheral sympathetic ganglia, with 30% of the cases developing within the adrenal medulla, although it can also occur within other regions of the body...

Full description

Saved in:
Bibliographic Details
Main Authors: Alfred Buhagiar, Duncan Ayers
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Analytical Cellular Pathology
Online Access:http://dx.doi.org/10.1155/2015/150634
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832546992787554304
author Alfred Buhagiar
Duncan Ayers
author_facet Alfred Buhagiar
Duncan Ayers
author_sort Alfred Buhagiar
collection DOAJ
description Neuroblastoma is a type of cancer that develops most often in infants and children under the age of five years. Neuroblastoma originates within the peripheral sympathetic ganglia, with 30% of the cases developing within the adrenal medulla, although it can also occur within other regions of the body such as nerve tissue in the spinal cord, neck, chest, abdomen, and pelvis. MicroRNAs (miRNAs) regulate cellular pathways, differentiation, apoptosis, and stem cell maintenance. Such miRNAs regulate genes involved in cellular processes. Consequently, they are implicated in the regulation of a spectrum of signaling pathways within the cell. In essence, the role of miRNAs in the development of cancer is of utmost importance for the understanding of dysfunctional cellular pathways that lead to the conversion of normal cells into cancer cells. This review focuses on highlighting the recent, important implications of miRNAs within the context of neuroblastoma basic research efforts, particularly concerning miRNA influences on cancer stem cell pathology and chemoresistance pathology for this condition, together with development of translational medicine approaches for novel diagnostic tools and therapies for this neuroblastoma.
format Article
id doaj-art-1773d189d358449e9a557893550210b1
institution Kabale University
issn 2210-7177
2210-7185
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Analytical Cellular Pathology
spelling doaj-art-1773d189d358449e9a557893550210b12025-02-03T06:46:20ZengWileyAnalytical Cellular Pathology2210-71772210-71852015-01-01201510.1155/2015/150634150634Chemoresistance, Cancer Stem Cells, and miRNA Influences: The Case for NeuroblastomaAlfred Buhagiar0Duncan Ayers1School of Clinical Sciences, Faculty of Medicine and Dentistry, University of Bristol, Bristol BS8 1TH, UKCentre for Molecular Medicine and Biobanking, University of Malta, Msida MSD 2080, MaltaNeuroblastoma is a type of cancer that develops most often in infants and children under the age of five years. Neuroblastoma originates within the peripheral sympathetic ganglia, with 30% of the cases developing within the adrenal medulla, although it can also occur within other regions of the body such as nerve tissue in the spinal cord, neck, chest, abdomen, and pelvis. MicroRNAs (miRNAs) regulate cellular pathways, differentiation, apoptosis, and stem cell maintenance. Such miRNAs regulate genes involved in cellular processes. Consequently, they are implicated in the regulation of a spectrum of signaling pathways within the cell. In essence, the role of miRNAs in the development of cancer is of utmost importance for the understanding of dysfunctional cellular pathways that lead to the conversion of normal cells into cancer cells. This review focuses on highlighting the recent, important implications of miRNAs within the context of neuroblastoma basic research efforts, particularly concerning miRNA influences on cancer stem cell pathology and chemoresistance pathology for this condition, together with development of translational medicine approaches for novel diagnostic tools and therapies for this neuroblastoma.http://dx.doi.org/10.1155/2015/150634
spellingShingle Alfred Buhagiar
Duncan Ayers
Chemoresistance, Cancer Stem Cells, and miRNA Influences: The Case for Neuroblastoma
Analytical Cellular Pathology
title Chemoresistance, Cancer Stem Cells, and miRNA Influences: The Case for Neuroblastoma
title_full Chemoresistance, Cancer Stem Cells, and miRNA Influences: The Case for Neuroblastoma
title_fullStr Chemoresistance, Cancer Stem Cells, and miRNA Influences: The Case for Neuroblastoma
title_full_unstemmed Chemoresistance, Cancer Stem Cells, and miRNA Influences: The Case for Neuroblastoma
title_short Chemoresistance, Cancer Stem Cells, and miRNA Influences: The Case for Neuroblastoma
title_sort chemoresistance cancer stem cells and mirna influences the case for neuroblastoma
url http://dx.doi.org/10.1155/2015/150634
work_keys_str_mv AT alfredbuhagiar chemoresistancecancerstemcellsandmirnainfluencesthecaseforneuroblastoma
AT duncanayers chemoresistancecancerstemcellsandmirnainfluencesthecaseforneuroblastoma